Inhibition of γ‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes
Top Cited Papers
- 2 January 2008
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 22 (5) , 1469-1478
- https://doi.org/10.1096/fj.07-9357com
Abstract
Alzheimer’s disease (AD) is the most common form of dementia and is associated with the deposition of the 39- to 43-amino acid β-amyloid peptide (Aβ) in the brain. C-terminal fragments (CTFs) of amyloid precursor protein (APP) can accumulate in endosomally derived multivesicular bodies (MVBs). These intracellular structures contain intraluminal vesicles that are released from the cell as exosomes when the MVB fuses with the plasma membrane. Here we have investigated the role of exosomes in the processing of APP and show that these vesicles contain APP-CTFs, as well as Aβ. In addition, inhibition of γ-secretase results in a significant increase in the amount of α- and β-secretase cleavage, further increasing the amount of APP-CTFs contained within these exosomes. We identify several key members of the secretase family of proteases (BACE, PS1, PS2, and ADAM10) to be localized in exosomes, suggesting they may be a previously unidentified site of APP cleavage. These results provide further evidence for a novel pathway in which APP fragments are released from cells and have implications for the analysis of APP processing and diagnostics for Alzheimer’s disease.—Sharples, R. A., Vella, L. J., Nisbet, R. M., Naylor, R., Perez, K., Barnham, K. J., Masters, C. L., Hill, A. F. Inhibition of γ-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes.Keywords
Funding Information
- National Health and Medical Research Council
This publication has 78 references indexed in Scilit:
- Alkalizing Drugs Induce Accumulation of Amyloid Precursor Protein By-products in Luminal Vesicles of Multivesicular BodiesJournal of Biological Chemistry, 2007
- Alzheimer's disease beta-amyloid peptides are released in association with exosomesProceedings of the National Academy of Sciences, 2006
- Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic MiceJournal of Neuroscience, 2005
- Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretaseBiochemical and Biophysical Research Communications, 2003
- Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ1–42 mutants of familial Alzheimer's disease at positions 21–23Biochemical and Biophysical Research Communications, 2002
- Distinct Intramembrane Cleavage of the β-Amyloid Precursor Protein Family Resembling γ-Secretase-like Cleavage of NotchJournal of Biological Chemistry, 2001
- APP Processing and Synaptic Plasticity in Presenilin-1 Conditional Knockout MiceNeuron, 2001
- Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerizationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Direct visualisation of the β-sheet structure of synthetic Alzheimer’s amyloidJournal of Molecular Biology, 2000
- Presenilin 1 Regulates the Processing of β-Amyloid Precursor Protein C-Terminal Fragments and the Generation of Amyloid β-Protein in Endoplasmic Reticulum and GolgiBiochemistry, 1998